Resona Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$291M Sell
241,202
-17,566
-7% -$17.9M 1.37% 12
2026
Q1
$236M Buy
258,768
+5,144
+2% +$5.22M 1.18% 12
2025
Q4
$273M Sell
253,624
-10,241
-4% -$9.79M 1.31% 11
2025
Q3
$200M Sell
263,865
-15,289
-5% -$11.4M 0.95% 14
2025
Q2
$217M Buy
279,154
+11,233
+4% +$8.73M 1.06% 13
2025
Q1
$221M Buy
267,921
+19,165
+8% +$15.9M 1.28% 13
2024
Q4
$192M Sell
248,756
-13,492
-5% -$11.2M 1.14% 12
2024
Q3
$232M Sell
262,248
-4,295
-2% -$3.86M 1.34% 10
2024
Q2
$241M Sell
266,543
-15,631
-6% -$12.5M 1.46% 8
2024
Q1
$220M Buy
+282,174
New +$201M 1.31% 8

Other funds holding LLY

Resona Asset Management's LLY Position: Q2 2026 in Review

Resona Asset Management reduced its Eli Lilly (LLY) stake by 6.8% in Q2 2026, selling an estimated $17.9M and leaving 241,202 shares worth $291M. The position accounts for 1.37% of the portfolio, ranked #12.

Resona Asset Management first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Resona Asset Management held 241,202 shares of Eli Lilly worth $291M as of Q2 2026.
  • Resona Asset Management sold 17,566 Eli Lilly shares in Q2 2026, an estimated $17.9M.
  • Eli Lilly made up 1.37% of Resona Asset Management's portfolio in Q2 2026, its #12 holding.
  • Resona Asset Management first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Resona Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.